EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

5-Methylcytidine RNA Epitranscriptomics in Women’s Health and Disease: Mechanisms and Clinical Implications

Qiwei Yang iD, Sana M Salih iD, Rongxue Wu, Itika Arora, Mira Mousa iD, Ayman Al-Hendy iD, Thomas G Boyer

Cells · 2026

DOI: 10.3390/cells15090847 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2026. Verfasst von Qiwei Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA. Hauptthemen laut MEDLINE: Women's Health, Cytidine, RNA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NIH HHS, National Institutes of Health (NIH) RO1.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemical modifications of RNA add a dynamic regulatory layer to gene expression beyond the genome and epigenome. Among these modifications, 5-methylcytidine (m5C) has emerged as a key epitranscriptomic modification that influences RNA stability, translation, localization, and stress responses across diverse biological systems. Recent advances in high-resolution mapping and functional interrogation of m5C have revealed its involvement in development, metabolism, immune regulation, and disease pathogenesis. Notably, many of these processes are highly relevant to women’s health, which is shaped by hormone-responsive tissues, reproductive transitions, and pregnancy-associated physiological adaptations. In this review, we provide a comprehensive and integrative overview of m5C RNA modification with a focus on its roles in female biology and disease. We summarize the molecular machinery responsible for m5C deposition, recognition, and regulation, as well as current detection technologies. We further highlight emerging evidence linking m5C dysregulation to early embryonic development, women-specific cancers, gynecologic and reproductive disorders, pregnancy complications, and metabolic and cardiovascular diseases. In addition, we discuss the interplay between m5C and sex hormone signaling, as well as the potential of m5C as a biomarker and therapeutic target. Finally, we identify key knowledge gaps, including the need for tissue-specific, longitudinal, single-cell, and spatial epitranscriptomic studies in women. By integrating epitranscriptomics into women’s health research, this review underscores m5C as a previously underappreciated regulatory layer with significant implications for precision medicine and clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Women's HealthCytidineRNAHumansFemaleEpitranscriptomicsEpitranscriptomeRNA MethylationPregnancyEpigenesis, Genetic

Stichwörter der Autor:innen

5-methylcytidine (m5C)RNA modificationbiomarkers and therapeuticscardiac remodelingepitranscriptomicsgynecologic diseaseshormone-responsive tissuesmetabolic homeostasisplacenta and pregnancyreproductive biologyvascular diseasewomen’s health

Substanzen

Cytidine5-methylcytidineRNA

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA.
  • Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA.
  • Section of Cardiology, Department of Medicine, Biological Sciences Division, University of Chicago, Chicago, IL 60637, USA.
  • Division of Cardiac Surgery, Department of Surgery, Dorothy M. Davis Heart & Lung Research Institute, Ohio State University, Columbus, OH 43210, USA.
  • Department of Public Health and Epidemiology, Khalifa University, Abu Dhabi P.O. Box 127788, United Arab Emirates.
  • Center for Biotechnology, Khalifa University, Abu Dhabi P.O. Box 127788, United Arab Emirates.

ORCID-Profile: Qiwei Yang, Sana M Salih, Mira Mousa, Ayman Al-Hendy

Förderung

  • NICHD NIH HHS
  • NIH HHS
  • National Institutes of Health (NIH) RO1

Zitieren

APA

Yang, Q., Salih, S. M., Wu, R., Arora, I., Mousa, M., Al-Hendy, A., & Boyer, T. G. (2026). 5-Methylcytidine RNA Epitranscriptomics in Women’s Health and Disease: Mechanisms and Clinical Implications. Cells. https://doi.org/10.3390/cells15090847

Vancouver

Yang Q, Salih SM, Wu R, Arora I, Mousa M, Al-Hendy A, et al. 5-Methylcytidine RNA Epitranscriptomics in Women’s Health and Disease: Mechanisms and Clinical Implications. Cells. 2026. doi:10.3390/cells15090847

BibTeX
@article{Yang2026,
  author = {Yang, Qiwei and Salih, Sana M and Wu, Rongxue and Arora, Itika and Mousa, Mira and Al-Hendy, Ayman and Boyer, Thomas G},
  title = {5-Methylcytidine RNA Epitranscriptomics in Women’s Health and Disease: Mechanisms and Clinical Implications},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15090847}
}
Kostenlos starten →